nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP3A7—Temsirolimus—kidney cancer	0.079	0.105	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.079	0.105	CbGbCtD
Triazolam—CYP3A5—Temsirolimus—kidney cancer	0.0593	0.0789	CbGbCtD
Triazolam—CYP3A4—Everolimus—kidney cancer	0.0342	0.0456	CbGbCtD
Triazolam—CYP2C8—Pazopanib—kidney cancer	0.0299	0.0399	CbGbCtD
Triazolam—CYP3A7—Paclitaxel—kidney cancer	0.0271	0.0361	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0271	0.0361	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0241	0.0321	CbGbCtD
Triazolam—CYP3A7—Sorafenib—kidney cancer	0.0241	0.0321	CbGbCtD
Triazolam—CYP3A7—Vincristine—kidney cancer	0.0234	0.0311	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0234	0.0311	CbGbCtD
Triazolam—CYP3A4—Temsirolimus—kidney cancer	0.0231	0.0308	CbGbCtD
Triazolam—CYP3A5—Erlotinib—kidney cancer	0.0222	0.0296	CbGbCtD
Triazolam—CYP2C9—Capecitabine—kidney cancer	0.0218	0.029	CbGbCtD
Triazolam—CYP2C8—Erlotinib—kidney cancer	0.0214	0.0284	CbGbCtD
Triazolam—CYP3A5—Paclitaxel—kidney cancer	0.0203	0.0271	CbGbCtD
Triazolam—CYP2C8—Paclitaxel—kidney cancer	0.0196	0.026	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0195	0.026	CbGbCtD
Triazolam—CYP3A7—Sunitinib—kidney cancer	0.0195	0.026	CbGbCtD
Triazolam—CYP3A5—Sorafenib—kidney cancer	0.0181	0.0241	CbGbCtD
Triazolam—CYP3A5—Vincristine—kidney cancer	0.0175	0.0234	CbGbCtD
Triazolam—CYP2C8—Sorafenib—kidney cancer	0.0174	0.0231	CbGbCtD
Triazolam—CYP3A5—Sunitinib—kidney cancer	0.0146	0.0195	CbGbCtD
Triazolam—CYP2C9—Paclitaxel—kidney cancer	0.0136	0.0182	CbGbCtD
Triazolam—CYP3A4—Pazopanib—kidney cancer	0.0121	0.0162	CbGbCtD
Triazolam—CYP2C9—Sorafenib—kidney cancer	0.0121	0.0161	CbGbCtD
Triazolam—CYP3A4—Erlotinib—kidney cancer	0.00866	0.0115	CbGbCtD
Triazolam—CYP3A4—Paclitaxel—kidney cancer	0.00793	0.0106	CbGbCtD
Triazolam—CYP3A4—Sorafenib—kidney cancer	0.00704	0.00938	CbGbCtD
Triazolam—CYP3A4—Vinblastine—kidney cancer	0.00696	0.00926	CbGbCtD
Triazolam—CYP3A4—Vincristine—kidney cancer	0.00684	0.00911	CbGbCtD
Triazolam—CYP3A4—Sunitinib—kidney cancer	0.00571	0.0076	CbGbCtD
Triazolam—CYP3A4—Doxorubicin—kidney cancer	0.00427	0.00569	CbGbCtD
Triazolam—Pain—Sorafenib—kidney cancer	0.00033	0.00164	CcSEcCtD
Triazolam—Constipation—Sorafenib—kidney cancer	0.00033	0.00164	CcSEcCtD
Triazolam—Malaise—Gemcitabine—kidney cancer	0.00033	0.00164	CcSEcCtD
Triazolam—Hypersensitivity—Vinblastine—kidney cancer	0.000329	0.00163	CcSEcCtD
Triazolam—Hypersensitivity—Everolimus—kidney cancer	0.000328	0.00163	CcSEcCtD
Triazolam—Tinnitus—Paclitaxel—kidney cancer	0.000328	0.00163	CcSEcCtD
Triazolam—Decreased appetite—Sunitinib—kidney cancer	0.000323	0.0016	CcSEcCtD
Triazolam—Mental disability—Doxorubicin—kidney cancer	0.000321	0.00159	CcSEcCtD
Triazolam—Asthenia—Vinblastine—kidney cancer	0.000321	0.00159	CcSEcCtD
Triazolam—Fatigue—Sunitinib—kidney cancer	0.000321	0.00159	CcSEcCtD
Triazolam—Asthenia—Everolimus—kidney cancer	0.000319	0.00158	CcSEcCtD
Triazolam—Pain—Sunitinib—kidney cancer	0.000318	0.00158	CcSEcCtD
Triazolam—Constipation—Sunitinib—kidney cancer	0.000318	0.00158	CcSEcCtD
Triazolam—Gastrointestinal pain—Sorafenib—kidney cancer	0.000316	0.00157	CcSEcCtD
Triazolam—Hypertension—Gemcitabine—kidney cancer	0.000316	0.00157	CcSEcCtD
Triazolam—Pruritus—Everolimus—kidney cancer	0.000315	0.00156	CcSEcCtD
Triazolam—Oedema—Vincristine—kidney cancer	0.000314	0.00156	CcSEcCtD
Triazolam—Stomatitis—Capecitabine—kidney cancer	0.000313	0.00155	CcSEcCtD
Triazolam—Jaundice—Capecitabine—kidney cancer	0.000313	0.00155	CcSEcCtD
Triazolam—Chest pain—Gemcitabine—kidney cancer	0.000311	0.00154	CcSEcCtD
Triazolam—Asthenia—Erlotinib—kidney cancer	0.000308	0.00153	CcSEcCtD
Triazolam—Discomfort—Gemcitabine—kidney cancer	0.000307	0.00153	CcSEcCtD
Triazolam—Erythema—Paclitaxel—kidney cancer	0.000306	0.00152	CcSEcCtD
Triazolam—Decreased appetite—Dactinomycin—kidney cancer	0.000306	0.00152	CcSEcCtD
Triazolam—Diarrhoea—Vinblastine—kidney cancer	0.000306	0.00152	CcSEcCtD
Triazolam—Abdominal pain—Sorafenib—kidney cancer	0.000305	0.00152	CcSEcCtD
Triazolam—Diarrhoea—Everolimus—kidney cancer	0.000305	0.00151	CcSEcCtD
Triazolam—Gastrointestinal pain—Sunitinib—kidney cancer	0.000304	0.00151	CcSEcCtD
Triazolam—Hyperhidrosis—Vincristine—kidney cancer	0.000304	0.00151	CcSEcCtD
Triazolam—Pruritus—Erlotinib—kidney cancer	0.000304	0.00151	CcSEcCtD
Triazolam—Fatigue—Dactinomycin—kidney cancer	0.000303	0.00151	CcSEcCtD
Triazolam—Flatulence—Paclitaxel—kidney cancer	0.000302	0.0015	CcSEcCtD
Triazolam—Pain—Dactinomycin—kidney cancer	0.000301	0.00149	CcSEcCtD
Triazolam—Tension—Paclitaxel—kidney cancer	0.0003	0.00149	CcSEcCtD
Triazolam—Anorexia—Vincristine—kidney cancer	0.0003	0.00149	CcSEcCtD
Triazolam—Dysgeusia—Paclitaxel—kidney cancer	0.0003	0.00149	CcSEcCtD
Triazolam—Hepatic failure—Doxorubicin—kidney cancer	0.000299	0.00148	CcSEcCtD
Triazolam—Oedema—Gemcitabine—kidney cancer	0.000298	0.00148	CcSEcCtD
Triazolam—Nervousness—Paclitaxel—kidney cancer	0.000297	0.00148	CcSEcCtD
Triazolam—Dizziness—Vinblastine—kidney cancer	0.000296	0.00147	CcSEcCtD
Triazolam—Dizziness—Everolimus—kidney cancer	0.000294	0.00146	CcSEcCtD
Triazolam—Muscle spasms—Paclitaxel—kidney cancer	0.000294	0.00146	CcSEcCtD
Triazolam—Abdominal pain—Sunitinib—kidney cancer	0.000294	0.00146	CcSEcCtD
Triazolam—Diarrhoea—Erlotinib—kidney cancer	0.000294	0.00146	CcSEcCtD
Triazolam—Feeling abnormal—Dactinomycin—kidney cancer	0.00029	0.00144	CcSEcCtD
Triazolam—Hyperhidrosis—Gemcitabine—kidney cancer	0.000288	0.00143	CcSEcCtD
Triazolam—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000288	0.00143	CcSEcCtD
Triazolam—Tremor—Paclitaxel—kidney cancer	0.000287	0.00142	CcSEcCtD
Triazolam—Hypersensitivity—Sorafenib—kidney cancer	0.000285	0.00141	CcSEcCtD
Triazolam—Insomnia—Vincristine—kidney cancer	0.000284	0.00141	CcSEcCtD
Triazolam—Anorexia—Gemcitabine—kidney cancer	0.000284	0.00141	CcSEcCtD
Triazolam—Vomiting—Vinblastine—kidney cancer	0.000284	0.00141	CcSEcCtD
Triazolam—Dizziness—Erlotinib—kidney cancer	0.000284	0.00141	CcSEcCtD
Triazolam—Ill-defined disorder—Paclitaxel—kidney cancer	0.000284	0.00141	CcSEcCtD
Triazolam—Vomiting—Everolimus—kidney cancer	0.000283	0.0014	CcSEcCtD
Triazolam—Paraesthesia—Vincristine—kidney cancer	0.000282	0.0014	CcSEcCtD
Triazolam—Agitation—Paclitaxel—kidney cancer	0.000281	0.0014	CcSEcCtD
Triazolam—Dermatitis—Everolimus—kidney cancer	0.00028	0.00139	CcSEcCtD
Triazolam—Headache—Vinblastine—kidney cancer	0.00028	0.00139	CcSEcCtD
Triazolam—Headache—Everolimus—kidney cancer	0.000279	0.00138	CcSEcCtD
Triazolam—Abdominal pain—Dactinomycin—kidney cancer	0.000278	0.00138	CcSEcCtD
Triazolam—Visual impairment—Capecitabine—kidney cancer	0.000278	0.00138	CcSEcCtD
Triazolam—Asthenia—Sorafenib—kidney cancer	0.000277	0.00138	CcSEcCtD
Triazolam—Malaise—Paclitaxel—kidney cancer	0.000276	0.00137	CcSEcCtD
Triazolam—Syncope—Paclitaxel—kidney cancer	0.000274	0.00136	CcSEcCtD
Triazolam—Hypersensitivity—Sunitinib—kidney cancer	0.000274	0.00136	CcSEcCtD
Triazolam—Decreased appetite—Vincristine—kidney cancer	0.000273	0.00136	CcSEcCtD
Triazolam—Pruritus—Sorafenib—kidney cancer	0.000273	0.00136	CcSEcCtD
Triazolam—Vomiting—Erlotinib—kidney cancer	0.000273	0.00136	CcSEcCtD
Triazolam—Fatigue—Vincristine—kidney cancer	0.000271	0.00135	CcSEcCtD
Triazolam—Dermatitis—Erlotinib—kidney cancer	0.000271	0.00134	CcSEcCtD
Triazolam—Palpitations—Paclitaxel—kidney cancer	0.00027	0.00134	CcSEcCtD
Triazolam—Insomnia—Gemcitabine—kidney cancer	0.00027	0.00134	CcSEcCtD
Triazolam—Headache—Erlotinib—kidney cancer	0.000269	0.00134	CcSEcCtD
Triazolam—Tinnitus—Capecitabine—kidney cancer	0.000269	0.00133	CcSEcCtD
Triazolam—Loss of consciousness—Paclitaxel—kidney cancer	0.000269	0.00133	CcSEcCtD
Triazolam—Pain—Vincristine—kidney cancer	0.000269	0.00133	CcSEcCtD
Triazolam—Constipation—Vincristine—kidney cancer	0.000269	0.00133	CcSEcCtD
Triazolam—Osteoarthritis—Doxorubicin—kidney cancer	0.000269	0.00133	CcSEcCtD
Triazolam—Paraesthesia—Gemcitabine—kidney cancer	0.000268	0.00133	CcSEcCtD
Triazolam—Asthenia—Sunitinib—kidney cancer	0.000267	0.00132	CcSEcCtD
Triazolam—Dyspnoea—Gemcitabine—kidney cancer	0.000266	0.00132	CcSEcCtD
Triazolam—Nausea—Vinblastine—kidney cancer	0.000265	0.00132	CcSEcCtD
Triazolam—Somnolence—Gemcitabine—kidney cancer	0.000265	0.00132	CcSEcCtD
Triazolam—Affect lability—Doxorubicin—kidney cancer	0.000265	0.00131	CcSEcCtD
Triazolam—Nausea—Everolimus—kidney cancer	0.000264	0.00131	CcSEcCtD
Triazolam—Diarrhoea—Sorafenib—kidney cancer	0.000264	0.00131	CcSEcCtD
Triazolam—Hypertension—Paclitaxel—kidney cancer	0.000264	0.00131	CcSEcCtD
Triazolam—Pruritus—Sunitinib—kidney cancer	0.000263	0.00131	CcSEcCtD
Triazolam—Chest pain—Paclitaxel—kidney cancer	0.000261	0.00129	CcSEcCtD
Triazolam—Anxiety—Paclitaxel—kidney cancer	0.00026	0.00129	CcSEcCtD
Triazolam—Decreased appetite—Gemcitabine—kidney cancer	0.000259	0.00129	CcSEcCtD
Triazolam—Hypersensitivity—Dactinomycin—kidney cancer	0.000259	0.00129	CcSEcCtD
Triazolam—Discomfort—Paclitaxel—kidney cancer	0.000257	0.00128	CcSEcCtD
Triazolam—Fatigue—Gemcitabine—kidney cancer	0.000257	0.00128	CcSEcCtD
Triazolam—Gastrointestinal pain—Vincristine—kidney cancer	0.000257	0.00128	CcSEcCtD
Triazolam—Dizziness—Sorafenib—kidney cancer	0.000256	0.00127	CcSEcCtD
Triazolam—Constipation—Gemcitabine—kidney cancer	0.000255	0.00127	CcSEcCtD
Triazolam—Pain—Gemcitabine—kidney cancer	0.000255	0.00127	CcSEcCtD
Triazolam—Nausea—Erlotinib—kidney cancer	0.000255	0.00127	CcSEcCtD
Triazolam—Dry mouth—Paclitaxel—kidney cancer	0.000255	0.00126	CcSEcCtD
Triazolam—Mood swings—Doxorubicin—kidney cancer	0.000255	0.00126	CcSEcCtD
Triazolam—Diarrhoea—Sunitinib—kidney cancer	0.000254	0.00126	CcSEcCtD
Triazolam—Ataxia—Doxorubicin—kidney cancer	0.000253	0.00125	CcSEcCtD
Triazolam—Asthenia—Dactinomycin—kidney cancer	0.000253	0.00125	CcSEcCtD
Triazolam—Confusional state—Paclitaxel—kidney cancer	0.000252	0.00125	CcSEcCtD
Triazolam—Erythema—Capecitabine—kidney cancer	0.000251	0.00125	CcSEcCtD
Triazolam—Oedema—Paclitaxel—kidney cancer	0.00025	0.00124	CcSEcCtD
Triazolam—Abdominal pain—Vincristine—kidney cancer	0.000249	0.00123	CcSEcCtD
Triazolam—Flatulence—Capecitabine—kidney cancer	0.000248	0.00123	CcSEcCtD
Triazolam—Dysgeusia—Capecitabine—kidney cancer	0.000246	0.00122	CcSEcCtD
Triazolam—Dizziness—Sunitinib—kidney cancer	0.000246	0.00122	CcSEcCtD
Triazolam—Feeling abnormal—Gemcitabine—kidney cancer	0.000246	0.00122	CcSEcCtD
Triazolam—Shock—Paclitaxel—kidney cancer	0.000246	0.00122	CcSEcCtD
Triazolam—Vomiting—Sorafenib—kidney cancer	0.000246	0.00122	CcSEcCtD
Triazolam—Tachycardia—Paclitaxel—kidney cancer	0.000244	0.00121	CcSEcCtD
Triazolam—Dermatitis—Sorafenib—kidney cancer	0.000243	0.00121	CcSEcCtD
Triazolam—Headache—Sorafenib—kidney cancer	0.000242	0.0012	CcSEcCtD
Triazolam—Muscle spasms—Capecitabine—kidney cancer	0.000241	0.0012	CcSEcCtD
Triazolam—Hyperhidrosis—Paclitaxel—kidney cancer	0.000241	0.0012	CcSEcCtD
Triazolam—Diarrhoea—Dactinomycin—kidney cancer	0.000241	0.0012	CcSEcCtD
Triazolam—Anorexia—Paclitaxel—kidney cancer	0.000238	0.00118	CcSEcCtD
Triazolam—Muscular weakness—Doxorubicin—kidney cancer	0.000237	0.00118	CcSEcCtD
Triazolam—Vomiting—Sunitinib—kidney cancer	0.000236	0.00117	CcSEcCtD
Triazolam—Tremor—Capecitabine—kidney cancer	0.000235	0.00117	CcSEcCtD
Triazolam—Dermatitis—Sunitinib—kidney cancer	0.000234	0.00116	CcSEcCtD
Triazolam—Ill-defined disorder—Capecitabine—kidney cancer	0.000233	0.00116	CcSEcCtD
Triazolam—Headache—Sunitinib—kidney cancer	0.000233	0.00116	CcSEcCtD
Triazolam—Hypersensitivity—Vincristine—kidney cancer	0.000232	0.00115	CcSEcCtD
Triazolam—Nausea—Sorafenib—kidney cancer	0.00023	0.00114	CcSEcCtD
Triazolam—Malaise—Capecitabine—kidney cancer	0.000227	0.00112	CcSEcCtD
Triazolam—Insomnia—Paclitaxel—kidney cancer	0.000226	0.00112	CcSEcCtD
Triazolam—Asthenia—Vincristine—kidney cancer	0.000226	0.00112	CcSEcCtD
Triazolam—Syncope—Capecitabine—kidney cancer	0.000225	0.00112	CcSEcCtD
Triazolam—Paraesthesia—Paclitaxel—kidney cancer	0.000224	0.00111	CcSEcCtD
Triazolam—Vomiting—Dactinomycin—kidney cancer	0.000224	0.00111	CcSEcCtD
Triazolam—Dyspnoea—Paclitaxel—kidney cancer	0.000223	0.00111	CcSEcCtD
Triazolam—Somnolence—Paclitaxel—kidney cancer	0.000222	0.0011	CcSEcCtD
Triazolam—Palpitations—Capecitabine—kidney cancer	0.000222	0.0011	CcSEcCtD
Triazolam—Nausea—Sunitinib—kidney cancer	0.000221	0.0011	CcSEcCtD
Triazolam—Loss of consciousness—Capecitabine—kidney cancer	0.000221	0.0011	CcSEcCtD
Triazolam—Dysuria—Doxorubicin—kidney cancer	0.000217	0.00108	CcSEcCtD
Triazolam—Decreased appetite—Paclitaxel—kidney cancer	0.000217	0.00108	CcSEcCtD
Triazolam—Hypertension—Capecitabine—kidney cancer	0.000217	0.00108	CcSEcCtD
Triazolam—Fatigue—Paclitaxel—kidney cancer	0.000215	0.00107	CcSEcCtD
Triazolam—Diarrhoea—Vincristine—kidney cancer	0.000215	0.00107	CcSEcCtD
Triazolam—Asthenia—Gemcitabine—kidney cancer	0.000214	0.00106	CcSEcCtD
Triazolam—Chest pain—Capecitabine—kidney cancer	0.000214	0.00106	CcSEcCtD
Triazolam—Pain—Paclitaxel—kidney cancer	0.000214	0.00106	CcSEcCtD
Triazolam—Constipation—Paclitaxel—kidney cancer	0.000214	0.00106	CcSEcCtD
Triazolam—Anxiety—Capecitabine—kidney cancer	0.000213	0.00106	CcSEcCtD
Triazolam—Discomfort—Capecitabine—kidney cancer	0.000211	0.00105	CcSEcCtD
Triazolam—Pruritus—Gemcitabine—kidney cancer	0.000211	0.00105	CcSEcCtD
Triazolam—Dry mouth—Capecitabine—kidney cancer	0.000209	0.00104	CcSEcCtD
Triazolam—Nausea—Dactinomycin—kidney cancer	0.000209	0.00104	CcSEcCtD
Triazolam—Dizziness—Vincristine—kidney cancer	0.000208	0.00103	CcSEcCtD
Triazolam—Drowsiness—Doxorubicin—kidney cancer	0.000207	0.00103	CcSEcCtD
Triazolam—Confusional state—Capecitabine—kidney cancer	0.000207	0.00103	CcSEcCtD
Triazolam—Feeling abnormal—Paclitaxel—kidney cancer	0.000206	0.00102	CcSEcCtD
Triazolam—Oedema—Capecitabine—kidney cancer	0.000205	0.00102	CcSEcCtD
Triazolam—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000204	0.00101	CcSEcCtD
Triazolam—Diarrhoea—Gemcitabine—kidney cancer	0.000204	0.00101	CcSEcCtD
Triazolam—Stomatitis—Doxorubicin—kidney cancer	0.000202	0.001	CcSEcCtD
Triazolam—Jaundice—Doxorubicin—kidney cancer	0.000202	0.001	CcSEcCtD
Triazolam—Shock—Capecitabine—kidney cancer	0.000202	0.001	CcSEcCtD
Triazolam—Tachycardia—Capecitabine—kidney cancer	0.0002	0.000993	CcSEcCtD
Triazolam—Vomiting—Vincristine—kidney cancer	0.0002	0.000992	CcSEcCtD
Triazolam—Hyperhidrosis—Capecitabine—kidney cancer	0.000198	0.000983	CcSEcCtD
Triazolam—Dermatitis—Vincristine—kidney cancer	0.000198	0.000983	CcSEcCtD
Triazolam—Abdominal pain—Paclitaxel—kidney cancer	0.000197	0.00098	CcSEcCtD
Triazolam—Headache—Vincristine—kidney cancer	0.000197	0.000978	CcSEcCtD
Triazolam—Anorexia—Capecitabine—kidney cancer	0.000195	0.00097	CcSEcCtD
Triazolam—Vomiting—Gemcitabine—kidney cancer	0.00019	0.000941	CcSEcCtD
Triazolam—Dermatitis—Gemcitabine—kidney cancer	0.000188	0.000933	CcSEcCtD
Triazolam—Headache—Gemcitabine—kidney cancer	0.000187	0.000927	CcSEcCtD
Triazolam—Nausea—Vincristine—kidney cancer	0.000187	0.000927	CcSEcCtD
Triazolam—Insomnia—Capecitabine—kidney cancer	0.000185	0.00092	CcSEcCtD
Triazolam—Paraesthesia—Capecitabine—kidney cancer	0.000184	0.000913	CcSEcCtD
Triazolam—Hypersensitivity—Paclitaxel—kidney cancer	0.000184	0.000913	CcSEcCtD
Triazolam—Dyspnoea—Capecitabine—kidney cancer	0.000183	0.000907	CcSEcCtD
Triazolam—Visual impairment—Doxorubicin—kidney cancer	0.000179	0.000889	CcSEcCtD
Triazolam—Asthenia—Paclitaxel—kidney cancer	0.000179	0.000889	CcSEcCtD
Triazolam—Decreased appetite—Capecitabine—kidney cancer	0.000178	0.000884	CcSEcCtD
Triazolam—Nausea—Gemcitabine—kidney cancer	0.000177	0.000879	CcSEcCtD
Triazolam—Fatigue—Capecitabine—kidney cancer	0.000177	0.000877	CcSEcCtD
Triazolam—Pruritus—Paclitaxel—kidney cancer	0.000177	0.000877	CcSEcCtD
Triazolam—Pain—Capecitabine—kidney cancer	0.000175	0.00087	CcSEcCtD
Triazolam—Constipation—Capecitabine—kidney cancer	0.000175	0.00087	CcSEcCtD
Triazolam—Tinnitus—Doxorubicin—kidney cancer	0.000173	0.00086	CcSEcCtD
Triazolam—Diarrhoea—Paclitaxel—kidney cancer	0.000171	0.000848	CcSEcCtD
Triazolam—Feeling abnormal—Capecitabine—kidney cancer	0.000169	0.000838	CcSEcCtD
Triazolam—Gastrointestinal pain—Capecitabine—kidney cancer	0.000168	0.000832	CcSEcCtD
Triazolam—Dizziness—Paclitaxel—kidney cancer	0.000165	0.00082	CcSEcCtD
Triazolam—Abdominal pain—Capecitabine—kidney cancer	0.000162	0.000804	CcSEcCtD
Triazolam—Erythema—Doxorubicin—kidney cancer	0.000162	0.000803	CcSEcCtD
Triazolam—Flatulence—Doxorubicin—kidney cancer	0.00016	0.000792	CcSEcCtD
Triazolam—Tension—Doxorubicin—kidney cancer	0.000159	0.000788	CcSEcCtD
Triazolam—Vomiting—Paclitaxel—kidney cancer	0.000159	0.000788	CcSEcCtD
Triazolam—Dysgeusia—Doxorubicin—kidney cancer	0.000159	0.000787	CcSEcCtD
Triazolam—Dermatitis—Paclitaxel—kidney cancer	0.000157	0.000781	CcSEcCtD
Triazolam—Nervousness—Doxorubicin—kidney cancer	0.000157	0.00078	CcSEcCtD
Triazolam—Headache—Paclitaxel—kidney cancer	0.000156	0.000777	CcSEcCtD
Triazolam—Muscle spasms—Doxorubicin—kidney cancer	0.000156	0.000772	CcSEcCtD
Triazolam—Hypersensitivity—Capecitabine—kidney cancer	0.000151	0.000749	CcSEcCtD
Triazolam—Ill-defined disorder—Doxorubicin—kidney cancer	0.00015	0.000745	CcSEcCtD
Triazolam—Agitation—Doxorubicin—kidney cancer	0.000149	0.000738	CcSEcCtD
Triazolam—Nausea—Paclitaxel—kidney cancer	0.000148	0.000736	CcSEcCtD
Triazolam—Asthenia—Capecitabine—kidney cancer	0.000147	0.00073	CcSEcCtD
Triazolam—Malaise—Doxorubicin—kidney cancer	0.000146	0.000725	CcSEcCtD
Triazolam—Syncope—Doxorubicin—kidney cancer	0.000145	0.00072	CcSEcCtD
Triazolam—Pruritus—Capecitabine—kidney cancer	0.000145	0.00072	CcSEcCtD
Triazolam—Palpitations—Doxorubicin—kidney cancer	0.000143	0.00071	CcSEcCtD
Triazolam—Loss of consciousness—Doxorubicin—kidney cancer	0.000142	0.000706	CcSEcCtD
Triazolam—Diarrhoea—Capecitabine—kidney cancer	0.00014	0.000696	CcSEcCtD
Triazolam—Hypertension—Doxorubicin—kidney cancer	0.00014	0.000694	CcSEcCtD
Triazolam—Chest pain—Doxorubicin—kidney cancer	0.000138	0.000684	CcSEcCtD
Triazolam—Anxiety—Doxorubicin—kidney cancer	0.000137	0.000682	CcSEcCtD
Triazolam—Discomfort—Doxorubicin—kidney cancer	0.000136	0.000676	CcSEcCtD
Triazolam—Dizziness—Capecitabine—kidney cancer	0.000136	0.000673	CcSEcCtD
Triazolam—Dry mouth—Doxorubicin—kidney cancer	0.000135	0.000669	CcSEcCtD
Triazolam—Confusional state—Doxorubicin—kidney cancer	0.000133	0.000661	CcSEcCtD
Triazolam—Oedema—Doxorubicin—kidney cancer	0.000132	0.000656	CcSEcCtD
Triazolam—Vomiting—Capecitabine—kidney cancer	0.00013	0.000647	CcSEcCtD
Triazolam—Shock—Doxorubicin—kidney cancer	0.00013	0.000645	CcSEcCtD
Triazolam—Dermatitis—Capecitabine—kidney cancer	0.000129	0.000641	CcSEcCtD
Triazolam—Tachycardia—Doxorubicin—kidney cancer	0.000129	0.00064	CcSEcCtD
Triazolam—Headache—Capecitabine—kidney cancer	0.000128	0.000637	CcSEcCtD
Triazolam—Hyperhidrosis—Doxorubicin—kidney cancer	0.000128	0.000634	CcSEcCtD
Triazolam—Anorexia—Doxorubicin—kidney cancer	0.000126	0.000625	CcSEcCtD
Triazolam—Nausea—Capecitabine—kidney cancer	0.000122	0.000604	CcSEcCtD
Triazolam—Insomnia—Doxorubicin—kidney cancer	0.00012	0.000593	CcSEcCtD
Triazolam—Paraesthesia—Doxorubicin—kidney cancer	0.000119	0.000589	CcSEcCtD
Triazolam—Dyspnoea—Doxorubicin—kidney cancer	0.000118	0.000585	CcSEcCtD
Triazolam—Somnolence—Doxorubicin—kidney cancer	0.000117	0.000583	CcSEcCtD
Triazolam—Decreased appetite—Doxorubicin—kidney cancer	0.000115	0.00057	CcSEcCtD
Triazolam—Fatigue—Doxorubicin—kidney cancer	0.000114	0.000565	CcSEcCtD
Triazolam—Constipation—Doxorubicin—kidney cancer	0.000113	0.000561	CcSEcCtD
Triazolam—Pain—Doxorubicin—kidney cancer	0.000113	0.000561	CcSEcCtD
Triazolam—Feeling abnormal—Doxorubicin—kidney cancer	0.000109	0.00054	CcSEcCtD
Triazolam—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000108	0.000536	CcSEcCtD
Triazolam—Abdominal pain—Doxorubicin—kidney cancer	0.000104	0.000518	CcSEcCtD
Triazolam—Hypersensitivity—Doxorubicin—kidney cancer	9.74e-05	0.000483	CcSEcCtD
Triazolam—Asthenia—Doxorubicin—kidney cancer	9.48e-05	0.00047	CcSEcCtD
Triazolam—Pruritus—Doxorubicin—kidney cancer	9.35e-05	0.000464	CcSEcCtD
Triazolam—Diarrhoea—Doxorubicin—kidney cancer	9.04e-05	0.000449	CcSEcCtD
Triazolam—Dizziness—Doxorubicin—kidney cancer	8.74e-05	0.000434	CcSEcCtD
Triazolam—Vomiting—Doxorubicin—kidney cancer	8.4e-05	0.000417	CcSEcCtD
Triazolam—Dermatitis—Doxorubicin—kidney cancer	8.32e-05	0.000413	CcSEcCtD
Triazolam—Headache—Doxorubicin—kidney cancer	8.28e-05	0.000411	CcSEcCtD
Triazolam—Nausea—Doxorubicin—kidney cancer	7.85e-05	0.000389	CcSEcCtD
Triazolam—GABRR2—Neuronal System—MAPK1—kidney cancer	2.74e-05	0.000576	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.71e-05	0.000571	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.71e-05	0.00057	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—RAF1—kidney cancer	2.69e-05	0.000566	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	2.69e-05	0.000565	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ACY1—kidney cancer	2.68e-05	0.000565	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.66e-05	0.000561	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—BRAF—kidney cancer	2.65e-05	0.000558	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—RAF1—kidney cancer	2.64e-05	0.000556	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PDHB—kidney cancer	2.64e-05	0.000555	CbGpPWpGaD
Triazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	2.64e-05	0.000555	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.63e-05	0.000554	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—POMC—kidney cancer	2.63e-05	0.000553	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—GSTM1—kidney cancer	2.62e-05	0.000551	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GPC3—kidney cancer	2.6e-05	0.000547	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—RAF1—kidney cancer	2.6e-05	0.000546	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	2.58e-05	0.000544	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—RAF1—kidney cancer	2.58e-05	0.000543	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.56e-05	0.000538	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.54e-05	0.000535	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—RAF1—kidney cancer	2.53e-05	0.000533	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CA2—kidney cancer	2.53e-05	0.000532	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.51e-05	0.000528	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	2.48e-05	0.000523	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.48e-05	0.000521	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CCBL1—kidney cancer	2.48e-05	0.000521	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.47e-05	0.000519	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALAD—kidney cancer	2.46e-05	0.000518	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.45e-05	0.000516	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	2.45e-05	0.000516	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.41e-05	0.000507	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.41e-05	0.000506	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ST3GAL2—kidney cancer	2.4e-05	0.000506	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.36e-05	0.000497	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALDH1A1—kidney cancer	2.35e-05	0.000494	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.32e-05	0.000489	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.31e-05	0.000486	CbGpPWpGaD
Triazolam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.3e-05	0.000484	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.29e-05	0.000482	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PDHB—kidney cancer	2.28e-05	0.00048	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—POMC—kidney cancer	2.28e-05	0.000479	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.27e-05	0.000477	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—MAPK1—kidney cancer	2.26e-05	0.000475	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SLC5A3—kidney cancer	2.25e-05	0.000474	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PGK1—kidney cancer	2.25e-05	0.000474	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.25e-05	0.000474	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—MAPK1—kidney cancer	2.22e-05	0.000468	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—RAF1—kidney cancer	2.21e-05	0.000466	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—LDHB—kidney cancer	2.21e-05	0.000465	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ACY1—kidney cancer	2.19e-05	0.00046	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPAT—kidney cancer	2.15e-05	0.000452	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GLIPR1—kidney cancer	2.15e-05	0.000452	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—RAF1—kidney cancer	2.15e-05	0.000452	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.15e-05	0.000452	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CCBL1—kidney cancer	2.15e-05	0.000452	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.1e-05	0.000443	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—MAPK1—kidney cancer	2.1e-05	0.000442	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—MAPK1—kidney cancer	2.08e-05	0.000437	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APRT—kidney cancer	2e-05	0.00042	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—FH—kidney cancer	2e-05	0.00042	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.98e-05	0.000417	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.94e-05	0.000408	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CA9—kidney cancer	1.92e-05	0.000403	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—MAPK1—kidney cancer	1.9e-05	0.0004	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.88e-05	0.000396	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GPC3—kidney cancer	1.88e-05	0.000395	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.86e-05	0.000392	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GLIPR1—kidney cancer	1.86e-05	0.000392	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPAT—kidney cancer	1.86e-05	0.000392	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PDHB—kidney cancer	1.86e-05	0.000391	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.85e-05	0.00039	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—POMC—kidney cancer	1.85e-05	0.00039	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—MAPK1—kidney cancer	1.84e-05	0.000388	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.84e-05	0.000387	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CA2—kidney cancer	1.83e-05	0.000384	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.82e-05	0.000383	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—MAPK1—kidney cancer	1.81e-05	0.000381	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALAD—kidney cancer	1.78e-05	0.000375	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—MAPK1—kidney cancer	1.78e-05	0.000375	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—MAPK1—kidney cancer	1.77e-05	0.000372	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—RAF1—kidney cancer	1.77e-05	0.000372	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CCBL1—kidney cancer	1.75e-05	0.000368	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.74e-05	0.000367	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ST3GAL2—kidney cancer	1.74e-05	0.000366	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—MAPK1—kidney cancer	1.74e-05	0.000365	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APRT—kidney cancer	1.73e-05	0.000364	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—FH—kidney cancer	1.73e-05	0.000364	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.73e-05	0.000364	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.7e-05	0.000359	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALDH1A1—kidney cancer	1.7e-05	0.000357	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.69e-05	0.000356	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—RAF1—kidney cancer	1.65e-05	0.000347	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.64e-05	0.000345	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CRABP1—kidney cancer	1.63e-05	0.000343	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SLC5A3—kidney cancer	1.63e-05	0.000343	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PGK1—kidney cancer	1.63e-05	0.000343	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—RAF1—kidney cancer	1.63e-05	0.000342	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GPC3—kidney cancer	1.63e-05	0.000342	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.62e-05	0.00034	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—LDHB—kidney cancer	1.6e-05	0.000336	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CA2—kidney cancer	1.58e-05	0.000333	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.58e-05	0.000332	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALAD—kidney cancer	1.54e-05	0.000324	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—MAPK1—kidney cancer	1.52e-05	0.000319	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPAT—kidney cancer	1.51e-05	0.000319	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.51e-05	0.000319	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ITPR2—kidney cancer	1.51e-05	0.000319	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ST3GAL2—kidney cancer	1.51e-05	0.000317	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.5e-05	0.000315	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.49e-05	0.000313	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.48e-05	0.000311	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALDH1A1—kidney cancer	1.47e-05	0.00031	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—RAF1—kidney cancer	1.45e-05	0.000304	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ACY1—kidney cancer	1.44e-05	0.000303	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—RAF1—kidney cancer	1.42e-05	0.000299	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.41e-05	0.000297	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PGK1—kidney cancer	1.41e-05	0.000297	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—FH—kidney cancer	1.41e-05	0.000296	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APRT—kidney cancer	1.41e-05	0.000296	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.4e-05	0.000294	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—RAF1—kidney cancer	1.39e-05	0.000292	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CA9—kidney cancer	1.38e-05	0.000291	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—LDHB—kidney cancer	1.38e-05	0.000291	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ACHE—kidney cancer	1.38e-05	0.000291	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTT1—kidney cancer	1.38e-05	0.000291	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.38e-05	0.00029	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.36e-05	0.000286	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GPC3—kidney cancer	1.32e-05	0.000279	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SCARB1—kidney cancer	1.31e-05	0.000275	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTGS1—kidney cancer	1.29e-05	0.000272	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CA2—kidney cancer	1.29e-05	0.000271	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PSMD7—kidney cancer	1.27e-05	0.000267	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALAD—kidney cancer	1.25e-05	0.000264	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PDHB—kidney cancer	1.23e-05	0.000258	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.22e-05	0.000258	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—POMC—kidney cancer	1.22e-05	0.000257	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—BCHE—kidney cancer	1.2e-05	0.000253	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CA9—kidney cancer	1.2e-05	0.000252	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.2e-05	0.000252	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.19e-05	0.00025	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SLC5A5—kidney cancer	1.19e-05	0.00025	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CRABP1—kidney cancer	1.18e-05	0.000248	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.17e-05	0.000247	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CCBL1—kidney cancer	1.15e-05	0.000242	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.15e-05	0.000242	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PGK1—kidney cancer	1.15e-05	0.000242	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SLC2A1—kidney cancer	1.15e-05	0.000241	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—LDHB—kidney cancer	1.13e-05	0.000237	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ITPR2—kidney cancer	1.09e-05	0.00023	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CRABP1—kidney cancer	1.02e-05	0.000215	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GLIPR1—kidney cancer	9.99e-06	0.00021	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPAT—kidney cancer	9.99e-06	0.00021	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTT1—kidney cancer	9.98e-06	0.00021	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ACHE—kidney cancer	9.98e-06	0.00021	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CA9—kidney cancer	9.76e-06	0.000205	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTP1—kidney cancer	9.57e-06	0.000201	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.54e-06	0.000201	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ITPR2—kidney cancer	9.48e-06	0.000199	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SCARB1—kidney cancer	9.45e-06	0.000199	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTGS1—kidney cancer	9.35e-06	0.000197	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APRT—kidney cancer	9.29e-06	0.000195	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—FH—kidney cancer	9.29e-06	0.000195	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PSMD7—kidney cancer	9.17e-06	0.000193	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ABCB1—kidney cancer	9.06e-06	0.000191	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTM1—kidney cancer	8.79e-06	0.000185	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.74e-06	0.000184	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GPC3—kidney cancer	8.73e-06	0.000184	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—BCHE—kidney cancer	8.69e-06	0.000183	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ACHE—kidney cancer	8.64e-06	0.000182	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTT1—kidney cancer	8.64e-06	0.000182	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SLC5A5—kidney cancer	8.59e-06	0.000181	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CA2—kidney cancer	8.49e-06	0.000179	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP1A1—kidney cancer	8.34e-06	0.000175	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CRABP1—kidney cancer	8.3e-06	0.000175	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SLC2A1—kidney cancer	8.29e-06	0.000175	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALAD—kidney cancer	8.28e-06	0.000174	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SCARB1—kidney cancer	8.18e-06	0.000172	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS1—kidney cancer	8.1e-06	0.00017	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.08e-06	0.00017	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PSMD7—kidney cancer	7.94e-06	0.000167	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALDH1A1—kidney cancer	7.9e-06	0.000166	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ITPR2—kidney cancer	7.71e-06	0.000162	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PGK1—kidney cancer	7.57e-06	0.000159	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.57e-06	0.000159	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—BCHE—kidney cancer	7.53e-06	0.000158	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SLC5A5—kidney cancer	7.44e-06	0.000157	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LDHB—kidney cancer	7.42e-06	0.000156	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SLC2A1—kidney cancer	7.18e-06	0.000151	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.11e-06	0.00015	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTT1—kidney cancer	7.04e-06	0.000148	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ACHE—kidney cancer	7.04e-06	0.000148	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.97e-06	0.000147	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTP1—kidney cancer	6.92e-06	0.000146	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SCARB1—kidney cancer	6.66e-06	0.00014	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS1—kidney cancer	6.59e-06	0.000139	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ABCB1—kidney cancer	6.55e-06	0.000138	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PSMD7—kidney cancer	6.46e-06	0.000136	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CA9—kidney cancer	6.44e-06	0.000135	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTM1—kidney cancer	6.36e-06	0.000134	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—POMC—kidney cancer	6.22e-06	0.000131	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—BCHE—kidney cancer	6.13e-06	0.000129	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.08e-06	0.000128	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.05e-06	0.000127	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP1A1—kidney cancer	6.03e-06	0.000127	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTP1—kidney cancer	5.99e-06	0.000126	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC2A1—kidney cancer	5.85e-06	0.000123	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.67e-06	0.000119	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ABCB1—kidney cancer	5.67e-06	0.000119	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTM1—kidney cancer	5.51e-06	0.000116	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CRABP1—kidney cancer	5.47e-06	0.000115	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP1A1—kidney cancer	5.22e-06	0.00011	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ITPR2—kidney cancer	5.09e-06	0.000107	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTGS2—kidney cancer	4.96e-06	0.000104	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.95e-06	0.000104	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTP1—kidney cancer	4.88e-06	0.000103	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ACHE—kidney cancer	4.64e-06	9.76e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTT1—kidney cancer	4.64e-06	9.76e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCB1—kidney cancer	4.62e-06	9.71e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—POMC—kidney cancer	4.49e-06	9.45e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTM1—kidney cancer	4.48e-06	9.43e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SCARB1—kidney cancer	4.39e-06	9.24e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS1—kidney cancer	4.35e-06	9.15e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTEN—kidney cancer	4.32e-06	9.1e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.29e-06	9.02e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PSMD7—kidney cancer	4.26e-06	8.97e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.25e-06	8.94e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—BCHE—kidney cancer	4.04e-06	8.5e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.99e-06	8.4e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—POMC—kidney cancer	3.89e-06	8.19e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.86e-06	8.11e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTGS2—kidney cancer	3.58e-06	7.54e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.49e-06	7.34e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTP1—kidney cancer	3.22e-06	6.77e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—POMC—kidney cancer	3.17e-06	6.66e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTEN—kidney cancer	3.13e-06	6.58e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS2—kidney cancer	3.1e-06	6.53e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CA—kidney cancer	3.05e-06	6.42e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCB1—kidney cancer	3.04e-06	6.41e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTM1—kidney cancer	2.96e-06	6.22e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.8e-06	5.9e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTEN—kidney cancer	2.71e-06	5.7e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS2—kidney cancer	2.53e-06	5.32e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CA—kidney cancer	2.2e-06	4.64e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTEN—kidney cancer	2.2e-06	4.64e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—POMC—kidney cancer	2.09e-06	4.4e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.91e-06	4.02e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS2—kidney cancer	1.67e-06	3.51e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.55e-06	3.27e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTEN—kidney cancer	1.45e-06	3.06e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.03e-06	2.16e-05	CbGpPWpGaD
